Shenyang Xingqi Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2024. For the half year, the company reported sales was CNY 880.19 million compared to CNY 671.17 million a year ago. Revenue was CNY 891.8 million compared to CNY 685.47 million a year ago.
Net income was CNY 169.32 million compared to CNY 87.75 million a year ago. Basic earnings per share from continuing operations was CNY 0.6929 compared to CNY 0.3643 a year ago. Diluted earnings per share from continuing operations was CNY 0.6929 compared to CNY 0.3643 a year ago.
